Cargando…
Meningococcal Vaccines: Current Status and Emerging Strategies
Neisseria meningitidis causes most cases of bacterial meningitis. Meningococcal meningitis is a public health burden to both developed and developing countries throughout the world. There are a number of vaccines (polysaccharide-based, glycoconjugate, protein-based and combined conjugate vaccines) t...
Autores principales: | McCarthy, Pumtiwitt C., Sharyan, Abeer, Sheikhi Moghaddam, Laleh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874653/ https://www.ncbi.nlm.nih.gov/pubmed/29495347 http://dx.doi.org/10.3390/vaccines6010012 |
Ejemplares similares
-
Investigation of bioluminescence-based assays for determination of kinetic parameters for the bifunctional Neisseria meningitidis serogroup W capsule polymerase
por: Sheikhi Moghaddam, Laleh, et al.
Publicado: (2021) -
Determination of the binding affinities of Neisseria meningitidis serogroup W capsule polymerase with two nucleotide sugar substrates
por: Sharyan, Abeer, et al.
Publicado: (2018) -
Recent and Future Advances in the Chemoenzymatic Synthesis of Homogeneous Glycans for Bacterial Glycoconjugate Vaccine Development
por: Adegbite, Ayobami, et al.
Publicado: (2021) -
Recent Applications of Dual-Stimuli Responsive Chitosan Hydrogel Nanocomposites as Drug Delivery Tools
por: McCarthy, Pumtiwitt C., et al.
Publicado: (2021) -
Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations
por: Martinón-Torres, Federico, et al.
Publicado: (2021)